Chemokines in the vascular inflammatory response of atherosclerosis (Q37652971)

21 August 2017

1 reference

title

Chemokines in the vascular inflammatory response of atherosclerosis (English)

1 reference

21 August 2017

0 references

1 reference

Christian Weber

0 references

Alma Zernecke

1 reference

21 August 2017

publication date

9 December 2009

1 reference

21 August 2017

published in

Cardiovascular Research

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

192-201

1 reference

Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Artery size, neointima, and remodeling: time for some standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Advances in coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Arterial remodeling. Mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Mechanisms of monocyte recruitment in vascular repair after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CCR2 deficiency decreases intimal hyperplasia after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Local Expression of Inflammatory Cytokines in Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Chemokines direct endothelial progenitors into tumor neovessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Interleukin-8 and its receptor CXCR2 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Macrophage migration inhibitory factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Neutrophil secretion products pave the way for inflammatory monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Evidence for a role of macrophage migration inhibitory factor in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

SDF-1α/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Band neutrophil count and the presence and severity of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

CCR7 signaling inhibits T cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Increased Th1 activity in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Platelet-derived CXC chemokines: old players in new games

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Fine-tuning leukocyte responses: towards a chemokine 'interactome'

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Chemokine: receptor structure, interactions, and antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP391

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP391

1 reference

21 August 2017

1 reference